Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tumor-informed liquid biopsy for monitoring thyroid cancer: a proof-of-concept study.

European thyroid journal - 1 Feb 2026

Thomaz Debora Mota Dias, Rocha Welbert Gomes, Albuquerque Julia Cavallari, Viana Aline de Oliveira Ribeiro, Velloni Julia Maranhão Fagundes, Elen Costa da Silva Renata, Curioni Otavio Alberto, Callegari Fabiano Mesquita, Martins João Roberto Maciel, Mello Biscolla Rosa Paula, Cerutti Janete Maria

Abstract excerpt

Objective: This proof-of-concept, cross-sectional study assessed the feasibility and clinical relevance of detecting circulating tumor DNA (ctDNA) and RNA (ctRNA) in plasma of patients with thyroid cancer. The analysis was performed concurrently with clinical and biochemical assessment to explore its value as a complementary tool for postoperative surveillance. Methods: Thirty-four patients whose primary tumors...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Circulating Tumor DNA

Share to Cross-Sectional Studies

Share to Feasibility Studies

Share to Liquid Biopsy

Share to Proof of Concept Study

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 41417016
DOI: 10.1530/ETJ-25-0255
PMCID: PMC13138592

Genes

ETV6
NTRK3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tumor-informed liquid biopsy for monitoring thyroid cancer: a proof-of-concept study.PMID 41417016Read ↗

Characterization of the Thyroid Cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.Semantic proximity Read ↗

Evaluating the prognostic potential of circulating cell-free DNA in advanced thyroid cancer.Semantic proximity Read ↗

Genomics and Multi-Omics to Guide Clinical Management in Thyroid CancerSemantic proximity Read ↗

Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center.Semantic proximity Read ↗

Emerging Biomarkers in Thyroid Practice and ResearchSemantic proximity Read ↗

Reporting of molecular test results from cell-free DNA analyses: expert consensus recommendations from the 2023 European Liquid Biopsy Society ctDNA WorkshopSemantic proximity Read ↗

Measurement of ctDNA Tumor Fraction Identifies Informative Negative Liquid Biopsy Results and Informs Value of Tissue Confirmation.Semantic proximity Read ↗

Clinical actionability of molecular testing in advanced thyroid cancer: a real-world cohort study.Semantic proximity Read ↗

Impact of the quality of resected thyroid cancer tissue sample on next-generation sequencing testing.Semantic proximity Read ↗

Liquid Biopsy-Based RET Mutation Profiling to Guide RET Inhibitor Treatment in Sporadic Medullary Thyroid Carcinoma May Be Useful in Cases with High Tumor Burden and Progressive Disease.Semantic proximity Read ↗

Facilitation of Definitive Cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules.Semantic proximity Read ↗

Next-Generation Sequencing in Differentiated Thyroid Cancer Patients Treated with Lenvatinib: Results and Challenges in Real-Life Practice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.